{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:27:35Z","timestamp":1787664455347,"version":"build-2736575974"},"reference-count":219,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00702-016-1596-4","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T14:19:09Z","timestamp":1470320349000},"page":"1255-1278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson\u2019s disease (PD): historical overview and future prospects"],"prefix":"10.1007","volume":"123","author":[{"given":"Toshiharu","family":"Nagatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Nagatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"issue":"2","key":"1596_CR1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21885","volume":"67","author":"M Asanuma","year":"2010","unstructured":"Asanuma M, Miyazaki I, Diaz-Corrales FJ, Kimoto Y, Takeshima M, Miyoshi K, Murata M (2010) Neuroprotective effects of zonisamide target astrocyte. Ann Neurol 67(2):239\u2013249","journal-title":"Ann Neurol"},{"key":"1596_CR2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.126.3270.400","volume":"126","author":"J Axelrod","year":"1957","unstructured":"Axelrod J (1957) O-Methylation of epinephrine and other catecholamines in vitro and invivo. Science 126:400\u2013401","journal-title":"Science"},{"key":"1596_CR3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-3565(25)25695-6","volume":"127","author":"J Axelrod","year":"1959","unstructured":"Axelrod J, Weil-Malherbe H, Tomchick R (1959) The physiological distribution of 3H-epinephrine and its metabolite epinephrine. J Pharmacol Exp Therap 127:251\u2013256","journal-title":"J Pharmacol Exp Therap"},{"issue":"13","key":"1596_CR4","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.85.13.4934","volume":"85","author":"AW Bach","year":"1988","unstructured":"Bach AW, Lan NC, Johnson DL, Abell CW, Bembenek ME, Kwan SW, Seeburg PH, Shih JC (1988) cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci USA 85(13):4934\u20134948","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1596_CR5","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1073\/pnas.85.10.3648","volume":"85","author":"EE Baetge","year":"1988","unstructured":"Baetge EE, Behringer RR, Messing A, Brinster RL, Palmiter RD (1988) Transgenic mice express the human phenylethanolamine N-methyltransferase gene in adrenal medulla and retina. Proc Natl Acad Sci USA 85(1):3648\u20133652","journal-title":"Proc Natl Acad Sci USA"},{"key":"1596_CR6","first-page":"59","volume":"101","author":"A Barbeau","year":"1969","unstructured":"Barbeau A (1969) l-Dopa therapy in Parkinson\u2019s disease. Can Med Aassoc J 101:59\u201368","journal-title":"Can Med Aassoc J"},{"key":"1596_CR7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.133.3465.1706-a","volume":"133","author":"A Barbeau","year":"1961","unstructured":"Barbeau A, Murphy GF, Sourkes TL (1961) Excretion of dopamine in diseases of basal ganglia. Science 133:120\u2013123","journal-title":"Science"},{"issue":"4","key":"1596_CR8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0301-0082(98)00028-8","volume":"55","author":"M Barkats","year":"1998","unstructured":"Barkats M, Bilang-Bleuel A, Buc-Caron MH, Castel-Barthe MN, Corti O, Finiels F, Horellou P, Ravah F, Sabate O, Mallet O (1998) Adenovirus in the brain: recent advances of gene therapy for neurodegenedrative diseases. Prog Neurobiol 55(4):333\u20133341","journal-title":"Prog Neurobiol"},{"key":"1596_CR9","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/215852b0","volume":"215","author":"G Bartholini","year":"1967","unstructured":"Bartholini G, Burkard WP, Pletscher A, Bates HM (1967) Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase. Nature 215:852\u2013853","journal-title":"Nature"},{"issue":"12","key":"1596_CR10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, Mackenzie G, Garcia-Osuna M, Panov AV, Greenamyre T (2000) Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 3(12):1301\u20131306","journal-title":"Nat Neurosci"},{"key":"1596_CR11","first-page":"787","volume":"73","author":"W Birkmayer","year":"1961","unstructured":"Birkmayer W, Hornykiewicz O (1961) Der l-3,4-Dioxyphenylalanin (l-DOPA)-Effekt bei der Parkinson-Akinese. Wien Klin Wochenschr 73:787\u2013788","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"1596_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01217333","volume":"210","author":"W Birkmayer","year":"1970","unstructured":"Birkmayer W, Mentasti M (1970) Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes) [Article in German]. Arch Psychiatr Nervenkr 210(1):29\u201335","journal-title":"Arch Psychiatr Nervenkr"},{"issue":"3\u20134","key":"1596_CR13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01253131","volume":"36","author":"W Birkmayer","year":"1975","unstructured":"Birkmayer W, Riederer P, Youdim MB, Linauer W (1975) The potentiation of the anti akinetic effect after l-dopa treatment by inhibitor of MAO-B, Deprenil. J Neural Transm 36(3\u20134):303\u2013326","journal-title":"J Neural Transm"},{"issue":"3\u20134","key":"1596_CR14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF01252816","volume":"58","author":"W Birkmayer","year":"1983","unstructured":"Birkmayer W, Birkmayer G, Lechner H, Riederer P (1983) dl-Threo-DOPS in Parkinson\u2019s disease: effects on orthostatic hypotension and dizziness. J Neural Transm 58(3\u20134):305\u2013313","journal-title":"J Neural Transm"},{"issue":"2","key":"1596_CR5000","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01245973","volume":"64","author":"W Birkmayer","year":"1985","unstructured":"Birkmayer W, Knoll J, Riederer P, Youdim MB, Hars V, Marton J (1985) Increased life expentancy resulting from addition of L-deprenyl to Medpar treatment in Parkinson's disease. J Neural Transm 64(2):113\u2013127","journal-title":"J Neural Transm"},{"key":"1596_CR15","volume-title":"PKU and BH4","year":"2006","unstructured":"Blau N (ed) (2006) PKU and BH4. SPS Publications, Weinsberg"},{"key":"1596_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","volume":"202","author":"D Blum-Degen","year":"1995","unstructured":"Blum-Degen D, M\u00fcller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin-1\u03b2 and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease paitiens. Neurosci Lett 202:17\u201320","journal-title":"Neurosci Lett"},{"key":"1596_CR17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1527-3458.2007.00020.x","volume":"13","author":"W Bonif\u00e1cio","year":"2007","unstructured":"Bonif\u00e1cio W, Plama PN, Almeida L, Soares-da-Silva P (2007) Catechol-O-methyltransferase and its inhibitors in Parkinson\u2019s disease. CNS Drug Rev 13:352\u2013379","journal-title":"CNS Drug Rev"},{"issue":"9","key":"1596_CR18","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/clinchem\/44.9.1897","volume":"44","author":"C Br\u00e4utigam","year":"1998","unstructured":"Br\u00e4utigam C, Wevers RA, Jansen RJT, Smeitink JAM, de Rijk-van Anden JF, Gabre\u00ebls FJM, Hoffmann GF (1998) Biochemical hall mark tyrosine hydroxylase deficiency. Clin Chem 44(9):1897\u20131904","journal-title":"Clin Chem"},{"key":"1596_CR002","doi-asserted-by":"crossref","unstructured":"Breakfield XO, Edelstein SB (1980) Inherited levels of A and B types of monoamine oxidase activity. Schizophr Bull 6 (2):281\u2013288","DOI":"10.1093\/schbul\/6.2.282"},{"issue":"7893","key":"1596_CR19","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0140-6736(74)92219-3","volume":"2","author":"DB Calne","year":"1974","unstructured":"Calne DB, Teychenne PF, Leigh PN, Bamji AN, Greennacre JK (1974) Treatment of parkinsonism with bromocriptine. Lancet 2(7893):1355\u20131366","journal-title":"Lancet"},{"issue":"2","key":"1596_CR20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0031-6997(25)07428-9","volume":"11","author":"A Carlsson","year":"1959","unstructured":"Carlsson A (1959) The occurrence, distribution and physiological role of catecholamines in the brain. Pharmacol Rev 11(2):490\u2013493","journal-title":"Pharmacol Rev"},{"issue":"4596","key":"1596_CR21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","volume":"180","author":"A Carlsson","year":"1957","unstructured":"Carlsson A, Lindqvist M, Magnusson T (1957) 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180(4596):1200","journal-title":"Nature"},{"issue":"2","key":"1596_CR22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0304-3940(85)90016-3","volume":"55","author":"MA Collins","year":"1985","unstructured":"Collins MA, Neafsey EJ (1985) Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism? Neurosci Lett 55(2):179\u2013184","journal-title":"Neurosci Lett"},{"issue":"7","key":"1596_CR23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM196902132800701","volume":"280","author":"GC Cotzias","year":"1969","unstructured":"Cotzias GC, Papavasiliou PS, Gellene R (1969) Modification of Parkinsonism\u2014chronic treatment with l-dopa. N Engl J Med 280(7):337\u2013345","journal-title":"N Engl J Med"},{"key":"1596_CR24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000132246","volume":"42","author":"SP Craig","year":"1986","unstructured":"Craig SP, Buckle VJ, Lamouroux A, Mallet J (1986) Localization of the human tyrosine hydroxylase gene to 11p15: gene duplication and evolution of metabolic pathways. Cytogenet Cell Genet 42:29\u201332","journal-title":"Cytogenet Cell Genet"},{"issue":"5","key":"1596_CR25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s004390050736","volume":"102","author":"JF Cubells","year":"1998","unstructured":"Cubells JF, van Kammen DP, Kelly ME, Anderson GM, O\u2019Connor DT, Price LH, Malison R, Rao PA, Kobayashi K, Nagatsu T, Gelerntner J (1998) Dopamine \u03b2-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 102(5):533\u2013540","journal-title":"Hum Genet"},{"issue":"1","key":"1596_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508(1):1\u201312","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"1596_CR27","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/stem.1060","volume":"30","author":"D DoI","year":"2012","unstructured":"DoI D, Morizane A, Kikuchi T, Onoe H, Hayashi T, Kawasaki T, Motono M, Sasai Y, Saiki H, Gomi M, Yoshikawa T, Hayashi H, Shinoyama M, Mohamed R, Suemori H, Miyamoto S, Takahashi J (2012) Prolonged mutation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived and dopaminergic function of human ESC-derived midbrain dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson\u2019s disease. Stem Cells 30(5):935\u2013945","journal-title":"Stem Cells"},{"issue":"3","key":"1596_CR28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","volume":"2","author":"D Doi","year":"2014","unstructured":"Doi D, Samata B, Katsukawa M, Kikuchi K, Morizane A, Ono Y, Sekiguchi K, Nakagawa M, Parmar M, Takahashi J (2014) Isolation of human induced pluripotent stem cell-drived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Rep 2(3):337\u2013350","journal-title":"Stem Cell Rep"},{"issue":"1","key":"1596_CR29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1471-4159.1996.67010019.x","volume":"67","author":"S Dumas","year":"1996","unstructured":"Dumas S, Hir HL, Bodedau-P\u00e9an S, Hirsch C, Thermes C, Mallet J (1996) New species of human tyrosine hydroxylase mRNA are produced in various amounts in adrenal medulla and are overexpressed in progressive supranuclear palsy. J Neurochem 67(1):19\u201325","journal-title":"J Neurochem"},{"issue":"5","key":"1596_CR30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","volume":"91","author":"PR Dunkley","year":"2004","unstructured":"Dunkley PR, Bobrovskaya L, Graham ME, von Nagy-Felsobuki EI, Dickson PW (2004) Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem 91(5):1025\u20131043","journal-title":"J Neurochem"},{"issue":"21","key":"1596_CR31","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1212\/01.wnl.0000312381.29287.ff","volume":"70","author":"JL Eberling","year":"2008","unstructured":"Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, Bankiewicz KS, Aminoff MJ (2008) Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 70(21):1980\u20131983","journal-title":"Neurology"},{"issue":"24","key":"1596_CR32","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H Ehringer","year":"1960","unstructured":"Ehringer H, Hornykiewicz O (1960) Verteilung von Noradrenalin und Dopamin im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wochenschr 38(24):1236\u20131239","journal-title":"Klin Wochenschr"},{"issue":"3","key":"1596_CR33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","volume":"56","author":"G Eisenhofer","year":"2004","unstructured":"Eisenhofer G, Kopin IJ, Goldstein DS (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56(3):331\u2013349","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1596_CR34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/mds.26102","volume":"30","author":"S Fahn","year":"2015","unstructured":"Fahn S (2015) The medical treatment of Parkinson disease from James Parkinson to George Cotzias. Mov Disord 30(1):4\u201318","journal-title":"Mov Disord"},{"issue":"17","key":"1596_CR35","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1089\/hum.1998.9.17-2527","volume":"9","author":"DS Fan","year":"1998","unstructured":"Fan DS, Ogawa M, Fujimoto K, Ikeguchi K, Ogasawara Y, Urabe M, Nishizawa M, Nakano I, Yoshida M, Nagatsu I, Ichinose H, Nagatsu T, Kurzman GJ, Ozawa K (1998) Behavioral recovery in 6-OHDA-lesioned rats by cotransduction with tyrosine hydroxylase and aromatic l-amino acid decarboxylase genes using two separate AAV vectors. Hum Gene Ther 9(17):2527\u20132533","journal-title":"Hum Gene Ther"},{"issue":"5","key":"1596_CR36","first-page":"519","volume":"12","author":"MS Fiandaca","year":"2010","unstructured":"Fiandaca MS, Bankiewicz KS (2010) Gene therapy for Parkinson\u2019s disease: from non-human primates to humans. Curr Opin Mol Ther 12(5):519\u2013529","journal-title":"Curr Opin Mol Ther"},{"issue":"7","key":"1596_CR37","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1021\/bi052283j","volume":"45","author":"PA Frantom","year":"2006","unstructured":"Frantom PA, Seravalli J, Ragsdale SW, Fitzpatrick PF (2006) Reduction and oxidation of the active site iron in tyrosine hydroxylase: kinetics and specificity. Biochemisty 45(7):2372\u20132379","journal-title":"Biochemisty"},{"issue":"1","key":"1596_CR38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2005.07.183","volume":"338","author":"H Fujisawa","year":"2005","unstructured":"Fujisawa H, Okuno S (2005) Regulatory mechanism of tyrosine hydroxylase activity. Biochem Biophys Res Commun 338(1):271\u2013276","journal-title":"Biochem Biophys Res Commun"},{"key":"1596_CR39","first-page":"177","volume":"41","author":"M Gerlach","year":"1994","unstructured":"Gerlach M, Youdim MB, Riederer P (1994) Is selegiline neuroprotective in Parkinson\u2019s disease? J Neural Transm Suppl 41:177\u2013188","journal-title":"J Neural Transm Suppl"},{"key":"1596_CR40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-211-45295-0_21","volume":"70","author":"M Gerlach","year":"2006","unstructured":"Gerlach M, Double KL, Youdim MB, Riederer P (2006) Potential source of increased iron in the substantia nigra of parkinsonian patients. J Neural Transm Suppl 70:133\u2013142","journal-title":"J Neural Transm Suppl"},{"issue":"8","key":"1596_CR41","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1172\/JCI45803","volume":"121","author":"DS Goldstein","year":"2011","unstructured":"Goldstein DS, Holmes C, Kopin IJ, Sharabi Y (2011) Intraneuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases. J Clin Invest 121(8):3320\u20133330","journal-title":"J Clin Invest"},{"issue":"5","key":"1596_CR42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/jnc.12345","volume":"126","author":"DS Goldstein","year":"2013","unstructured":"Goldstein DS, Sullivan P, Holmes C, Miller GW, Alter S, Strong R, Mash DC, Kopin IJ, Sharabi Y (2013) Determination of buildup of the toxic dopamine metabolite DOPAL in Parkinson\u2019s disease. J Neurochem 126(5):591\u2013603","journal-title":"J Neurochem"},{"issue":"2","key":"1596_CR43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/jnc.12766","volume":"131","author":"DS Goldstein","year":"2014","unstructured":"Goldstein DS, Sullivan P, Holmes C, Miller GW, Sharabi Y, Kopin IJ (2014) A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson\u2019s disease. J Neurochem 131(2):219\u2013228","journal-title":"J Neurochem"},{"issue":"7","key":"1596_CR44","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nsb0797-578","volume":"4","author":"KE Goodwill","year":"1997","unstructured":"Goodwill KE, Sabatier C, Marks C, Raag R, Fitzpatrick PF, Stevens RC (1997) Crystal structure of tyrosine hydroxylase at 2.5 A and its implications for inherited neurodegenerative diseases. Nature Struct Biol 4(7):578\u2013585","journal-title":"Nature Struct Biol"},{"key":"1596_CR45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-3-7091-6499-0_27","volume":"Suppl 52","author":"ME G\u00f6tz","year":"1998","unstructured":"G\u00f6tz ME, Breithaupt W, Sautter J, Kupsch A, Schwarz J, Ortel WH, Youdim MB, Riederer P, Gerlach M (1998) Chronic TVP-1012 (rasagiline) dose-activity response of monoamine oxidase A and B in the brain of the common marmoset. J Neural Transm Suppl 52:271\u2013278","journal-title":"J Neural Transm"},{"issue":"6114","key":"1596_CR46","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/326707a0","volume":"326","author":"B Grima","year":"1987","unstructured":"Grima B, Lamouroux A, Boni C, Julian JF, Javoy-Agid F, Mallet J (1987) A single human gene encoding multiple tyrosine hydroxylase with different predicted functional characteristics. Nature 326(6114):707\u2013711","journal-title":"Nature"},{"key":"1596_CR001","doi-asserted-by":"crossref","unstructured":"Hare ML (1928) Tyramine oxidase: a new enzyme system in liver. Biochem J 22(4):968\u2013979","DOI":"10.1042\/bj0220968"},{"issue":"12","key":"1596_CR47","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00702-012-0898-4","volume":"119","author":"DJ Hare","year":"2012","unstructured":"Hare DJ, Gerlach M, Riederer P (2012) Consideration for measuring iron in post-mortem tissue of Parkinson\u2019s disease patients. J Neural Transm 119(12):1515\u20131521","journal-title":"J Neural Transm"},{"issue":"5","key":"1596_CR48","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1046\/j.1471-4159.2002.00881.x","volume":"81","author":"JW Haycock","year":"2002","unstructured":"Haycock JW (2002) Species differences in the expression of multiple tyrosine hydroxylase protein isoforms. J Neurochem 81(5):947\u2013995","journal-title":"J Neurochem"},{"issue":"Suppl 11","key":"1596_CR49","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18","author":"EC Hirsch","year":"2012","unstructured":"Hirsch EC, Vyas S, Hunot S (2012) Neuroinflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 11):S210\u2013S212","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"1596_CR50","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T (2016) The incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Neuroepideminology 46(4):292\u2013300","journal-title":"Neuroepideminology"},{"issue":"6","key":"1596_CR51","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/ana.10632","volume":"54","author":"GF Hoffmann","year":"2003","unstructured":"Hoffmann GF, Assmann B, Br\u00e4utigam C, Dionisi-Vici C, H\u00e4ussler M, de Klert JBC, Naumann M, Steenbergen-Spanjers GCH, Strassburg H-M, Wevers RA (2003) Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Ann Neurol 54(6):S56\u2013S65","journal-title":"Ann Neurol"},{"key":"1596_CR52","first-page":"277","volume-title":"Handbook of chemical neuroanatomy. Classical transmitters in the CNS, part 1","author":"T H\u00f6kfelt","year":"1984","unstructured":"H\u00f6kfelt T, Martensson Bj\u00f6rklund A, Kleinau S, Goldstein M (1984) Distribution maps of tyrosine-hydroxylase immunoreactive neurons in the rat brain. In: Bj\u00f6rklund A, H\u00f6kfelt T (eds) Handbook of chemical neuroanatomy. Classical transmitters in the CNS, part 1, vol 2. Elsevier, Amsterdam, pp 277\u2013379"},{"issue":"3","key":"1596_CR53","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/0006-291X(91)90472-J","volume":"176","author":"S Ichikawa","year":"1991","unstructured":"Ichikawa S, Sasaoka T, Nagatsu T (1991) Primary structure of mouse tyrosine hydroxylase deduced from its cDNA. Biochem Biophys Res Commun 176(3):1610\u20131616","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1596_CR54","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/0006-291X(89)91772-5","volume":"164","author":"H Ichinose","year":"1989","unstructured":"Ichinose H, Kurosawa Y, Titani K, Fujita K, Nagatsu T (1989) Isolation and characterization of a cDNA clone encoding human aromatic l-amino acid decarboxylase. Biochem Biophys Res Commun 164(3):1024\u20131030","journal-title":"Biochem Biophys Res Commun"},{"issue":"46","key":"1596_CR55","doi-asserted-by":"crossref","first-page":"11546","DOI":"10.1021\/bi00161a036","volume":"31","author":"H Ichinose","year":"1992","unstructured":"Ichinose H, Sumi-Ichinose C, Ohye T, Hagino Y, Fujita K, Nagatsu T (1992) Tissue-specific alternative splicing of the first exon generates two types of mRNAs in human aromatic l-amino acid decarboxylase. Biochemistry 31(46):11546\u201311550","journal-title":"Biochemistry"},{"issue":"1","key":"1596_CR56","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/bbrc.1993.2024","volume":"195","author":"H Ichinose","year":"1993","unstructured":"Ichinose H, Ohye T, Fujita K, Yoshida M, Ueda S, Nagatsu T (1993) Increase heterogeneity of tyrosine hydroxylase in humans. Biochem Biophys Res Commun 195(1):158\u2013165","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"1596_CR57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02250926","volume":"8","author":"H Ichinose","year":"1994","unstructured":"Ichinose H, Ohye T, Fujita K, Pantucek F, Lange K, Riederer P, Nagatsu T (1994a) Quantification of mRNA of tyrosine hydroxylase and aromatic l-amino acid decarboxylase in the substantia nigra in Parkinson\u2019s disease and schizophrenia. J Neural Transm P-D Sect 8(1\u20132):149\u2013158","journal-title":"J Neural Transm P-D Sect"},{"issue":"3","key":"1596_CR58","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1194-236","volume":"8","author":"H Ichinose","year":"1994","unstructured":"Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M, Nomura Y, Endo K, Tanaka H, Tsuji S, Fujita K, Nagatsu T (1994b) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 8(3):236\u2013242","journal-title":"Nat Genet"},{"issue":"17","key":"1596_CR59","doi-asserted-by":"crossref","first-page":"10062","DOI":"10.1074\/jbc.270.17.10062","volume":"270","author":"H Ichinose","year":"1995","unstructured":"Ichinose H, Ohye T, Matsuda Y, Hori T, Blau A, Burlina A, Rouse B, Matalon R, Fujita K, Nagatsu T (1995) Characterization of mouse and human GTP cyclohydrolase I deficiency: mutations in patients with GTP cyclohydrolase I deficiency. J Biol Chem 270(17):10062\u201310071","journal-title":"J Biol Chem"},{"issue":"12","key":"1596_CR60","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1515\/BC.1999.175","volume":"380","author":"H Ichinose","year":"1999","unstructured":"Ichinose H, Suzuki T, Inagaki H, Ohye T, Nagatsu T (1999) Molecular genetics of dopa-responsive dystonia. Biol Chem 380(12):1355\u20131364","journal-title":"Biol Chem"},{"issue":"7","key":"1596_CR61","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0092-8674(01)00407-X","volume":"105","author":"Y Imai","year":"2001","unstructured":"Imai Y, Soda H, Inoue H, Hattori N, Mizuno Y, Takahashi R (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105(7):891\u2013902","journal-title":"Cell"},{"issue":"2","key":"1596_CR62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00401-004-0919-y","volume":"109","author":"K Imamura","year":"2005","unstructured":"Imamura K, Hishikawa N, Ono K, Suzuki H, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2005) Cytokine production of activated microglia and decrease in neurotrophic factors in neurons in the hippocampus of Lewy body disease brain. Acta Neropathol 109(2):141\u2013150","journal-title":"Acta Neropathol"},{"issue":"51","key":"1596_CR63","doi-asserted-by":"crossref","first-page":"39718","DOI":"10.1074\/jbc.M110.137034","volume":"285","author":"S Ishikawa","year":"2010","unstructured":"Ishikawa S, Taira T, Takahashi-Niki K, Niki T, Ariga H, Iguchi-Ariga SM (2010) Human DJ-1-specific transcriptional activation of tyrosine hydroxylase gene. J Biol Chem 285(51):39718\u201339731","journal-title":"J Biol Chem"},{"issue":"47","key":"1596_CR64","doi-asserted-by":"crossref","first-page":"15673","DOI":"10.1021\/bi9914255","volume":"38","author":"C Itagaki","year":"1999","unstructured":"Itagaki C, Isobe T, Taoka M, Natsume N, Horigome T, Omata S, Ichinose H, Nagatsu T, Greene LA, Ichimura T (1999) Stimulous-coupled interaction of tyrosine hydroxylase with 14-3-3 proteins. Biochemistry 38(47):15673\u201315680","journal-title":"Biochemistry"},{"issue":"5","key":"1596_CR65","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1469-1809.2000.6450375.x","volume":"64","author":"RJRJ Janssen","year":"2000","unstructured":"Janssen RJRJ, Wevers RA, H\u00e4ussler M, Luyten JAFM, Steenbergen-Spanjers GCH, Hoffmann GF, Nagatsu T, van den Heuvel LPWJ (2000) A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder. Ann Hum Genet 64(5):375\u2013382","journal-title":"Ann Hum Genet"},{"issue":"5692","key":"1596_CR66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"JW Kababien","year":"1979","unstructured":"Kababien JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277(5692):93\u201396","journal-title":"Nature"},{"issue":"9996","key":"1596_CR67","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912","journal-title":"Lancet"},{"issue":"2","key":"1596_CR68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1083\/jcb.201402104","volume":"205","author":"LA Kane","year":"2014","unstructured":"Kane LA, Lazarou M, Fogel AI, Li Y, Yamano K, Sarraf SA, Banerjee S, Youle RJ (2014) PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol 205(2):143\u2013153","journal-title":"J Cell Biol"},{"issue":"3","key":"1596_CR69","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0006-291X(87)90742-X","volume":"146","author":"N Kaneda","year":"1987","unstructured":"Kaneda N, Kobayashi K, Ichinose H, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T (1987) Isolation of a novel cDNA clone for human tyrosine hydroxylase: alternative mRNA splicing produces four kinds of mRNA from a single gene. Biochem Biophys Res Commun 146(3):971\u2013975","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"1596_CR70","doi-asserted-by":"crossref","first-page":"7672","DOI":"10.1016\/S0021-9258(18)68551-5","volume":"263","author":"N Kaneda","year":"1988","unstructured":"Kaneda N, Ichinose H, Kobayashi K, Oka K, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T (1988) Molecular cloning of cDNA and chromosomal assignment of the gene for human phenylethanolamine-N-methyltransferase, the enzyme for epinephrine biosynthesis. J Biol Chem 263(16):7672\u20137677","journal-title":"J Biol Chem"},{"issue":"4","key":"1596_CR71","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0896-6273(91)90061-4","volume":"6","author":"N Kaneda","year":"1991","unstructured":"Kaneda N, Sasaoka T, Kobayashi K, Kiuchi K, Nagatsu I, Kurosawa Y, Fujita K, Yokoyama M, Nomura T, Katsuki M, Nagatsu T (1991) Tissue-specific and high-level expression of the human tyrosine hydroxylase gene in transgenic mice. Neuron 6(4):583\u2013594","journal-title":"Neuron"},{"issue":"5479","key":"1596_CR72","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1126\/science.289.5479.633","volume":"289","author":"S Kaneko","year":"2000","unstructured":"Kaneko S, Hikida T, Watanabe D, Ichinose H, Nagatsu T, Kreitman RJ, Pastan I, Nakanishi S (2000) Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function. Science 289(5479):633\u2013637","journal-title":"Science"},{"key":"1596_CR73","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-12-800149-3.00003-2","volume":"87","author":"B Kantor","year":"2014","unstructured":"Kantor B, Bailey RM, Wimberley K, Kalburgi SN, Gray SJ (2014) Methods for gene transfer to the central nevous system. Adv Genet 87:125\u2013197","journal-title":"Adv Genet"},{"key":"1596_CR74","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1073\/pnas.50.6.1085","volume":"50","author":"S Kaufman","year":"1963","unstructured":"Kaufman S (1963) The structure of the phenylalanine-hydroxylation cofactor. Proc Natl Acad Sci USA 50:1085\u20131093","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1596_CR75","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1042\/BJ20140334","volume":"460","author":"A Kazlauskaite","year":"2014","unstructured":"Kazlauskaite A, Kondapalli C, Gourlay R, Campbell DG, Ritorto MS, Hofmann K, Alessi DR, Knebel A, Trost M, Muqit MM (2014) Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser 65. Biochem J 460(1):127\u2013139","journal-title":"Biochem J"},{"issue":"6676","key":"1596_CR76","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori H, Yamamura S, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392(6676):605\u2013608","journal-title":"Nature"},{"issue":"2","key":"1596_CR77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0891-0618(96)00111-1","volume":"10","author":"K Kitahama","year":"1996","unstructured":"Kitahama K, Sakamoto N, Jouvet A, Nagatsu I, Pearson J (1996) Dopamine-beta-hydroxylase immunoreactive neurons in the human brain stem. J Chem Neuroanat 10(2):137\u2013146","journal-title":"J Chem Neuroanat"},{"issue":"2","key":"1596_CR78","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jchemneu.2009.06.010","volume":"38","author":"K Kitahama","year":"2009","unstructured":"Kitahama K, Ikemoto K, Jouvet A, Araneda S, Nagatsu I, Raynaud B, Nishimura A, Nishi K, Niwa S (2009) Aromatic l-amino acid decarboxylase-immunoreactive structures in human midbrain, pons, and medulla. J Chem Neuroanat 38(2):130\u2013140","journal-title":"J Chem Neuroanat"},{"issue":"7","key":"1596_CR79","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/hmg\/4.7.1209","volume":"4","author":"PM Knappskog","year":"1995","unstructured":"Knappskog PM, Flatmark T, Mallet J, L\u00fcdecke B, Baltholom\u00e9 K (1995) Recessively inherited l-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet 4(7):1209\u20131212","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1596_CR80","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbrc.2005.07.186","volume":"338","author":"K Kobayashi","year":"2005","unstructured":"Kobayashi K, Nagatsu T (2005) Molecular genetics of tyrosine 3-monooxygenase and inherited diseases. Biochem Biophys Res Commun 338(1):267\u2013270","journal-title":"Biochem Biophys Res Commun"},{"key":"1596_CR81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-12-386525-0.00007-X","volume-title":"Primers on the autonomic nervous system","author":"K Kobayashi","year":"2012","unstructured":"Kobayashi K, Nagatsu T (2012) Tyrosine hydroxylase. In: Robertson D, Biggioni I, Burnstock G, Low PA, Paton JFR (eds) Primers on the autonomic nervous system. Academic Press\/Elsevier, Oxford, pp 45\u201347"},{"issue":"16","key":"1596_CR82","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1093\/nar\/15.16.6733","volume":"15","author":"K Kobayashi","year":"1987","unstructured":"Kobayashi K, Kaneda N, Ichinose H, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T (1987) Isolation of a full-length cDNA clone encoding human tyrosine hydroxylase type 3. Nucleic Acids Res 15(16):6733","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1596_CR83","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/oxfordjournals.jbchem.a122386","volume":"103","author":"K Kobayashi","year":"1988","unstructured":"Kobayashi K, Kaneda N, Ichinose H, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T (1988) Structures of the human tyrosine hydroxylase gene: alternative splicing from a single gene accounts for generation of four mRNA subtypes. J Biochem 103(6):907\u2013912","journal-title":"J Biochem"},{"issue":"3","key":"1596_CR84","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/nar\/17.3.1089","volume":"17","author":"K Kobayashi","year":"1989","unstructured":"Kobayashi K, Kurosawa Y, Fujita K, Nagatsu T (1989) Human dopamine beta-hydroxylase gene: two mRNA types having different 3\u2032-terminal region are produced through alternative polyadenylation. Nucleic Acids Res 17(3):1089\u20131102","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1596_CR85","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1073\/pnas.89.5.1631","volume":"89","author":"K Kobayashi","year":"1992","unstructured":"Kobayashi K, Sasaoka T, Morita S, Nagatsu I, Iguchi A, Kurosawa Y, Fujita K, Nomura T, Kimura M, Katsuki M, Nagatsu T (1992) Genetic alteration of catecholamine specificity in transgenic mice. Proc Natl Acad Sci USA 89(5):1631\u20131635","journal-title":"Proc Natl Acad Sci USA"},{"issue":"47","key":"1596_CR86","doi-asserted-by":"crossref","first-page":"29725","DOI":"10.1016\/S0021-9258(18)43941-5","volume":"269","author":"K Kobayashi","year":"1994","unstructured":"Kobayashi K, Morita S, Mizuguchi T, Sawada H, Yamada K, Nagatsu I, Fujita K, Nagatsu T (1994) Functional high level expression of human dopamine beta-hydroxylase in transgenic mice. J Biol Chem 269(47):29725\u201329731","journal-title":"J Biol Chem"},{"key":"1596_CR87","first-page":"27232","volume":"270","author":"K Kobayashi","year":"1995","unstructured":"Kobayashi K, Morita S, Sawada H, Mizuguchi T, Yamada K, Nagatsu I, Hata T, Watanabe Y, Fujita K, Nagatsu T (1995a) Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J Biol Chem 270:27232\u201327243","journal-title":"J Biol Chem"},{"issue":"4","key":"1596_CR88","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1073\/pnas.92.4.1132","volume":"92","author":"K Kobayashi","year":"1995","unstructured":"Kobayashi K, Morita S, Sawada H, Mizuguchi T, Yamada K, Nagatsu I, Fujita K, Kreitman RJ, Pastan Y, Nagatsu T (1995b) Immunotoxin-mediated conditional disruption of specific neurons in transgenic mice. Proc Natl Acad Sci USA 92(4):1132\u20131136","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1596_CR89","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1523\/JNEUROSCI.20-06-02418.2000","volume":"20","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi K, Noda Y, Matsushita N, Nishii K, Sawada H, Nagatsu T, Nakahara D, Fukabori R, Yasoshima Y, Yamamoto T, Miura M, Kano M, Miyama T, Miyamoto Y, Nabeshima T (2000) Modest neuropsychological deficits caused by reduced noradrenaline metabolism in mice heterozygous for a mutated tyrosine hydroxylase gene. J Neurosci 20(6):2418\u20132426","journal-title":"J Neurosci"},{"issue":"4","key":"1596_CR90","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0031-6997(25)06859-0","volume":"37","author":"IJ Kopin","year":"1985","unstructured":"Kopin IJ (1985) Catecholamine metabolism: basic and clinical significance. Pharmacol Rev 37(4):333\u2013364","journal-title":"Pharmacol Rev"},{"key":"1596_CR91","first-page":"57","volume":"41","author":"IJ Kopin","year":"1994","unstructured":"Kopin IJ (1994) Monoamine oxidase and catecholamine metabolism. J Neural Transm Suppol 41:57\u201367","journal-title":"J Neural Transm Suppol"},{"issue":"6","key":"1596_CR92","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1046\/j.1471-4159.1995.65062633.x","volume":"65","author":"Y Kotake","year":"1995","unstructured":"Kotake Y, Tasaki Y, Makino Y, Ohta S, Hirobe M (1995) 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-producing agent: a novel endogenous amine in mouse brain and parkinsonian CSF. J Neurochem 65(6):2633\u20132638","journal-title":"J Neurochem"},{"key":"1596_CR93","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-bioeng-071813-104938","volume":"17","author":"MA Kotterman","year":"2015","unstructured":"Kotterman MA, Chalberg TW, Schaffer DV (2015) Viral vectors for gene therapy: translational and clinical outlooks. Annu Rev Biomed Eng 17:63\u201389","journal-title":"Annu Rev Biomed Eng"},{"issue":"7503","key":"1596_CR94","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nature13392","volume":"510","author":"F Koyano","year":"2014","unstructured":"Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, Kimura Y, Tsutia H, Yoshihara H, Hirokawa T, Endo T, Fon EA, Trempe JF, Saeki Y, Tanaka K, Matsuda N (2014) Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510(7503):370\u2013375","journal-title":"Nature"},{"key":"1596_CR95","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/cpt1971124678","volume":"12","author":"I Kuruma","year":"1971","unstructured":"Kuruma I, Bartholini G, Tissot R, Pletscher A (1971) The metabolism of l-3-O-methyl-dopa, a precursor of dopa in man. Clin Pharmacol Ther 12:672\u2013682","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1596_CR96","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1152\/physrev.00042.2006","volume":"89","author":"R Kvetnansky","year":"2006","unstructured":"Kvetnansky R, Sabban EL, Palkovits M (2006) Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev 89(2):535\u2013606","journal-title":"Physiol Rev"},{"issue":"12","key":"1596_CR97","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.79.12.3881","volume":"79","author":"A Lamouroux","year":"1982","unstructured":"Lamouroux A, Faucon Biguet N, Samolyk D, Privat A, Salomon JC, Pujol JF, Mallet J (1982) Identification of cDNA clone coding for rat tyrosine hydroxylase antigen. Proc Natl Acad Sci USA 79(12):3881\u20133885","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"1596_CR98","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1002\/j.1460-2075.1987.tb02734.x","volume":"6","author":"A Lamouroux","year":"1987","unstructured":"Lamouroux A, Vigny A, Faucon Biguet N, Darmon MC, Franck R, Henry JP, Mallet J (1987) The primary structure of human dopamine-beta-hydroxylase: insights into the relationship between the soluble and the membrane-bound forms of the enzyme. EMBO J 6(13):3931\u20133937","journal-title":"EMBO J"},{"key":"1596_CR003","unstructured":"Lange KW, Rausch WD, Gsell W, Naumann M, Oestreichr E, Riederer P (1994) Neuroprotection by dopamine agonists. J Neural Transm Suppl 43:183\u2013201"},{"issue":"4587","key":"1596_CR99","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219(4587):979\u2013980","journal-title":"Science"},{"issue":"1","key":"1596_CR100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-4159.1988.tb13241.x","volume":"50","author":"A Bourdell\u00e8s Le","year":"1988","unstructured":"Le Bourdell\u00e8s A, Boularand S, Bonic C, Horellou P, Dumas S, Grima B, Mallet J (1988) Analysis of the 5\u2032 region of the human tyrosine hydroxylase generate multiple regulated tyrosine hydroxylase isoforms. J Neurochem 50(1):142\u2013148","journal-title":"J Neurochem"},{"issue":"26","key":"1596_CR101","doi-asserted-by":"crossref","first-page":"17644","DOI":"10.1074\/jbc.M512194200","volume":"281","author":"IT Lehman","year":"2006","unstructured":"Lehman IT, Bobrovskaya L, Gordon SL, Dunkley PR, Dickson PW (2006) Differential regulation of the human tyrosine hydroxylase isoforms via hierarchical phosphorylation. J Biol Chem 281(26):17644\u201317651","journal-title":"J Biol Chem"},{"key":"1596_CR102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)27006-9","volume":"148","author":"M Levitt","year":"1965","unstructured":"Levitt M, Spector S, Sjoerdsma A, Udenfriend S (1965) Elucidation of the rate-limiting step in nor-epinephrine biosynthesis in the perfused guinea-pig heart. J Pharmacol Exp Therap 148:1\u20138","journal-title":"J Pharmacol Exp Therap"},{"issue":"2","key":"1596_CR103","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0306-4522(93)90267-J","volume":"54","author":"DA Lewis","year":"1993","unstructured":"Lewis DA, Melchitzky DS, Haycock JW (1993) Four isoforms of human tyrosine hydroxylase are expressed in human brain. Neuroscience 54(2):477\u2013492","journal-title":"Neuroscience"},{"issue":"1","key":"1596_CR104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(94)91360-9","volume":"656","author":"DA Lewis","year":"1994","unstructured":"Lewis DA, Melchitzky DS, Haycock JW (1994) Expression and distribution of two isoforms of tyrosine hydroxylase in macaque monkey brain. Brain Res 656(1):1\u201313","journal-title":"Brain Res"},{"issue":"3","key":"1596_CR105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3565(25)30363-0","volume":"153","author":"KG Lloyd","year":"1975","unstructured":"Lloyd KG, Davidson L, Hornykiewicz O (1975) The neurochemistry of Parkinson\u2019s disease: effect of l-DOPA therapy. J Pharmacol Exp Ther 153(3):453\u2013464","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1596_CR106","first-page":"123","volume":"93","author":"B L\u00fcdecke","year":"1994","unstructured":"L\u00fcdecke B, Dworniczak B, Bartholom\u00e9 K (1994) A point mutation in the tyrosine hydroxylase associated with Segawa\u2019s syndrome. Hum Genet 93(1):123\u2013125","journal-title":"Hum Genet"},{"issue":"7","key":"1596_CR107","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/hmg\/5.7.1023","volume":"5","author":"B L\u00fcdecke","year":"1996","unstructured":"L\u00fcdecke B, Knappskog PM, Clayton PT, Surtees RAH, Clelland JD, Heales SJR, Brand MP, Bartholom\u00e9 K, Flattmark T (1996) Recessively inherited l-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum Mol Genet 5(7):1023\u20131028","journal-title":"Hum Mol Genet"},{"key":"1596_CR108","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-3271-9_1","volume":"1382","author":"FP Manfredsson","year":"2016","unstructured":"Manfredsson FP (2016) Introduction to viral vectors and other delivery methods for gene therapy of the nervous system. Methods Mol Biol 1382:3\u201318","journal-title":"Methods Mol Biol"},{"issue":"5","key":"1596_CR109","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0892-0362(02)00212-X","volume":"24","author":"K Matsubara","year":"2002","unstructured":"Matsubara K, Aoyama K, Suno M, Awaya T (2002) N-Methylation underlying Parkinson\u2019s disease. Neurotoxicol Teratol 24(5):593\u2013598","journal-title":"Neurotoxicol Teratol"},{"issue":"2","key":"1596_CR110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1083\/jcb.200910140","volume":"189","author":"N Matsuda","year":"2010","unstructured":"Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA, Sou YS, Saiki S, Kawajiri S, Sato F, Kimura M, Komatsu M, Hattori N, Tanaka K (2010) PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 189(2):211\u2013221","journal-title":"J Cell Biol"},{"issue":"5","key":"1596_CR111","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/oxfordjournals.jbchem.a135401","volume":"98","author":"S Matsuura","year":"1985","unstructured":"Matsuura S, Sugimoto T, Murata S, Sugawara Y, Iwasaki H (1985) Stereochemistry of biopterin cofactor and facile methods for determination of the stereochemistry of a biologically active 5,6,7,8-terahydropterin. J Biochem 98(5):1341\u20131348","journal-title":"J Biochem"},{"issue":"39","key":"1596_CR112","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1523\/JNEUROSCI.0896-06.2006","volume":"26","author":"JR Mazzulli","year":"2006","unstructured":"Mazzulli JR, Mishizen AJ, Giasson BI, Lynch DR, Thomas SA, Nakashima A, Nagatsu T, Ota A, Ischiopoulos H (2006) Cytosolic catechols inhibit \u03b1-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. J Neurosci 26(39):10068\u201310078","journal-title":"J Neurosci"},{"issue":"2","key":"1596_CR113","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"PL McGeer","year":"1995","unstructured":"McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Review 21(2):195\u2013218","journal-title":"Brain Res Review"},{"issue":"3","key":"1596_CR114","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1098-2396(19991201)34:3<241::AID-SYN8>3.0.CO;2-E","volume":"34","author":"CJ Messer","year":"1999","unstructured":"Messer CJ, Son JH, Joh TH, Beck KD, Nestler EJ (1999) Regulation of tyrosine hydroxylase transcription in ventral midbrain by glial cell line-derived neurotrophic factor. Synapse 34(3):241\u2013243","journal-title":"Synapse"},{"issue":"Suppl 1","key":"1596_CR115","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/S1353-8020(13)70018-X","volume":"20","author":"TM Michel","year":"2014","unstructured":"Michel TM, K\u00e4sbauer L, Gsell W, Jecel J, Sheldrick AJ, Cortese M, Nickl-Jackschat T, Gr\u00fcnblatt E, Riederer P (2014) Aldehyde dehydrogenase 2 in sporadic Parkinson\u2019s disease. Parkinsonism Relat Disord 20(Suppl 1):S68\u2013S72","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"1596_CR116","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","volume":"90","author":"PP Michel","year":"2016","unstructured":"Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson\u2019s disease. Neuron 90(4):675\u2013691","journal-title":"Neuron"},{"issue":"3","key":"1596_CR117","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","volume":"163","author":"Y Mizuno","year":"1989","unstructured":"Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson\u2019s disease. Biochem Biophys Res Commun 163(3):1450\u20131455","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1596_CR118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNF.0b013e3181bbf45c","volume":"33","author":"Y Mizuno","year":"2010","unstructured":"Mizuno Y, Kondo T, Kuno S, Nomoto N, Yanagisawa N (2010) Early addition of selegiline to l-Dopa treatment is beneficial for patients with Parkinson disease. Clin Neuropharmacol 33(1):1\u20134","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"1596_CR119","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0022-510X(95)00336-Z","volume":"137","author":"H Mochizuki","year":"1996","unstructured":"Mochizuki H, Goto K, Mori H, Mizuno Y (1996) Histochemical detection of apoptosis in Parkinson\u2019s disease. J Neurol Sci 137(2):120\u2013123","journal-title":"J Neurol Sci"},{"issue":"1","key":"1596_CR120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF02737084","volume":"10","author":"SM Mockus","year":"1998","unstructured":"Mockus SM, Yohrling GJ 4th, Vrana KE (1998) Tyrosine hydroxylase and tryptophan hydroxylase do not form heterotetramers. J Mol Neurosci 10(1):45\u201351","journal-title":"J Mol Neurosci"},{"issue":"1","key":"1596_CR121","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01244634","volume":"72","author":"M Mogi","year":"1988","unstructured":"Mogi M, Harada N, Kiuchi K, Kojima K, Kondo T, Narabayashi H, Rausch D, Riederer P, Jellinger K, Nagatsu T (1988a) Homo-specific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain. J Neural Transm 72(1):77\u201382","journal-title":"J Neural Transm"},{"issue":"2","key":"1596_CR122","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0197-0186(88)90126-X","volume":"12","author":"M Mogi","year":"1988","unstructured":"Mogi M, Harada M, Kojima K, Inagaki H, Kondo T, Narabayashi H, Arai T, Teradaira R, Fujita K, Kiuchi K, Nagatsu T (1988b) Sandwich enzyme immunoassay of dopamine beta-hydoxylase in cerebrospinal fluid from control and Parkinsonian patients. Neurochem Int 12(2):187\u2013191","journal-title":"Neurochem Int"},{"issue":"4","key":"1596_CR123","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.1988.tb10572.x","volume":"50","author":"M Mogi","year":"1988","unstructured":"Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu T (1988c) Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, l-3,4-dihydroxyphenylalanine decarboxylase, dopamine \u03b2-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus. J Neurochem 50(4):1053\u201310556","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"1596_CR124","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994) Tumor necrosis factor-alpha (TNF-factor) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165(1\u20132):208\u2013210","journal-title":"Neurosci Lett"},{"issue":"1","key":"1596_CR125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","volume":"211","author":"M Mogi","year":"1996","unstructured":"Mogi M, Harada M, Narabayashi H, Inagaki H, Minami M, Nagatsu T (1996) Interleukin (IL)-1\u03b2, IL-2, IL-4, IL-6 and transforming growth factor-alpha are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson\u2019s disease. Neurosci Lett 211(1):13\u201316","journal-title":"Neurosci Lett"},{"issue":"1","key":"1596_CR126","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00463-2","volume":"270","author":"M Mogi","year":"1999","unstructured":"Mogi M, Togari A, Kondo T, Mizuno Y, Komure O, Kuno S, Ichinose H, Nagatsu T (1999) Brain derived neurotrophic factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson\u2019s disease. Neurosci Lett 270(1):45\u201348","journal-title":"Neurosci Lett"},{"issue":"3","key":"1596_CR127","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s007020050028","volume":"107","author":"M Mogi","year":"2000","unstructured":"Mogi M, Togari A, Kondo T, Mizuno Y, Komure O, Kuno S, Ichinose H, Nagatsu T (2000) Caspase activities and tumor necrosis factor receptor R1 level are elevated in the substantia nigra in Parkinson\u2019s disease. J Neural Transm 107(3):335\u2013341","journal-title":"J Neural Transm"},{"issue":"1","key":"1596_CR128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","volume":"414","author":"M Mogi","year":"2007","unstructured":"Mogi M, Kondo T, Mizuno Y, Nagatsu T (2007) p53 protein, interferon-\u03b3, and NF-\u03baB levels are elevated in the parkinsonian brain. Neurosci Lett 414(1):94\u201397","journal-title":"Neurosci Lett"},{"issue":"4","key":"1596_CR129","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","volume":"1","author":"A Morizane","year":"2013","unstructured":"Morizane A, Doi D, Kikuchi T, Okita K, Hotta A, Kawasaki T, Hayashi T, Onoe H, Shiina T, Yamanaka S, Takahashi J (2013) Direct comparison of autologous and allogenic transplantation of iPSC-derived neural cells in the brain of a non-human primate. Stem Cell Rep 1(4):283\u2013292","journal-title":"Stem Cell Rep"},{"issue":"3","key":"1596_CR130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/10430340252792486","volume":"13","author":"S Muramatsu","year":"2002","unstructured":"Muramatsu S, Fujimoto K, Ikeguchi K, Shizuma N, Kawasaki K, Ono F, Shen Y, Wang LJ, Mizukami H, Kume A, Matsumura M, Nagatsu I, Urano F, Ichinose H, Nagatsu T, Terano K, Nakano I, Ozawa K (2002) Behavioral recovery in a primate model of Parkinson\u2019s disease by triple transduction of cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes. Hum Gene Ther 13(3):345\u2013354","journal-title":"Hum Gene Ther"},{"issue":"9","key":"1596_CR131","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/mt.2010.135","volume":"18","author":"S Muramatsu","year":"2010","unstructured":"Muramatsu S, Fujimoto K, Kano S (2010) A phase 1 study of aromatic l-amino acid decarboxylase gene therapy for Parkinson\u2019s disease. Mol Ther 18(9):1731\u20131745","journal-title":"Mol Ther"},{"issue":"4","key":"1596_CR132","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0168-0102(01)00298-X","volume":"41","author":"M Murata","year":"2001","unstructured":"Murata M, Horiuchi E, Kanazawa I (2001) Zonisamide has beneficial effects on Parkinson\u2019s disease patients. Neurosci Res 41(4):397\u2013399","journal-title":"Neurosci Res"},{"issue":"1","key":"1596_CR133","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/01.wnl.0000250236.75053.16","volume":"68","author":"M Murata","year":"2007","unstructured":"Murata M, Hasegawa K, Kanazawa I (2007) The Japan Zonisamide on PD Study Group: zonisamide improves motor function in Parkinson disease. A randomized, double-blind study. Neurology 68(1):45\u201350","journal-title":"Neurology"},{"key":"1596_CR134","unstructured":"Nagatsu T (1973) Biochemistry of catecholamines. University of Tokyo Press, Tokyo, University Park Press, Baltimore"},{"issue":"10","key":"1596_CR135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0968-0004(77)90112-8","volume":"2","author":"T Nagatsu","year":"1977","unstructured":"Nagatsu T (1977) Dopamine \u03b2-hydroxylase in blood and cerebrospinal fluid. Trends Biochem Sci 2(10):217\u2013219","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"1596_CR136","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0168-0102(91)90001-F","volume":"12","author":"T Nagatsu","year":"1991","unstructured":"Nagatsu T (1991) Genes for human catecholamine-synthesizing enzymes. Neurosci Res 12(2):315\u2013345","journal-title":"Neurosci Res"},{"key":"1596_CR137","first-page":"15","volume-title":"Essays in biochemistry","author":"T Nagatsu","year":"1995","unstructured":"Nagatsu T (1995) Tyrosine hydroxylase: human isoforms, structure and regulation on physiology and pathology. In: Apps DK, Tipton KF (eds) Essays in biochemistry, vol 30. Portland Press, London, pp 15\u201335"},{"issue":"2","key":"1596_CR138","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-0102(97)00083-7","volume":"29","author":"T Nagatsu","year":"1997","unstructured":"Nagatsu T (1997) Isoquinoline neurotoxins in the brain and Parkinson\u2019s disease. Neurosci Res 29(2):99\u2013111","journal-title":"Neurosci Res"},{"issue":"5","key":"1596_CR139","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0892-0362(02)00209-X","volume":"24","author":"T Nagatsu","year":"2002","unstructured":"Nagatsu T (2002) Amine-related neurotoxins in Parkinson\u2019s disease: past, present and future. Neurotoxicol Teratol 24(5):565\u2013569","journal-title":"Neurotoxicol Teratol"},{"issue":"1\u20132","key":"1596_CR140","first-page":"11","volume":"25","author":"T Nagatsu","year":"2004","unstructured":"Nagatsu T (2004) Progress in monoamine oxidase (MAO) research in relation to genetic engineering. Neuro Toxicol 25(1\u20132):11\u201320","journal-title":"Neuro Toxicol"},{"issue":"10","key":"1596_CR141","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2183\/pjab.82.388","volume":"82","author":"T Nagatsu","year":"2006","unstructured":"Nagatsu T (2006) The catecholamine system in health and disease: relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymes. Proc Jpn Acad Ser B 82(10):388\u2013415","journal-title":"Proc Jpn Acad Ser B"},{"issue":"1","key":"1596_CR142","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1373\/clinchem.2008.109215","volume":"55","author":"T Nagatsu","year":"2009","unstructured":"Nagatsu T (2009) Simple photometric assay of dopamine \u03b2-hydroxylase in human blood useful in clinical study. Clin Chem 55(1):193\u2013194","journal-title":"Clin Chem"},{"issue":"1","key":"1596_CR143","first-page":"203","volume":"98C","author":"T Nagatsu","year":"1991","unstructured":"Nagatsu T, Ichinose H (1991) Comparative studies on the structure of human tyrosine hydroxylase with those of the enzyme of various mammals. Comp Biochem Physiol 98C(1):203\u2013210","journal-title":"Comp Biochem Physiol"},{"issue":"1","key":"1596_CR144","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1006912523846","volume":"19","author":"T Nagatsu","year":"1999","unstructured":"Nagatsu T, Ichinose H (1999) Molecular biology of catecholamine-related enzymes in relation to Parkinson\u2019s disease. Cell Mol Neurobiol 19(1):57\u201366","journal-title":"Cell Mol Neurobiol"},{"issue":"8","key":"1596_CR145","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","volume":"11","author":"T Nagatsu","year":"2005","unstructured":"Nagatsu T, Sawada M (2005) Inflammatory process in Parkinson\u2019s disease: role of cytokines. Curr Phamac Des 11(8):999\u20131016","journal-title":"Curr Phamac Des"},{"issue":"4\u20136","key":"1596_CR146","first-page":"781","volume":"26","author":"T Nagatsu","year":"2006","unstructured":"Nagatsu T, Sawada M (2006a) Cellular and molecular mechanisms of Parkinson\u2019s disease. Cell Mol Neurobiol 26(4\u20136):781\u2013801","journal-title":"Neuroteurobiology"},{"key":"1596_CR147","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-211-33328-0_7","volume":"Suppl 71","author":"T Nagatsu","year":"2006","unstructured":"Nagatsu T, Sawada M (2006b) Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson\u2019s disease: possible implication of glial cells. J Neural Transm Suppl 71:53\u201365","journal-title":"J Neural Transm"},{"key":"1596_CR148","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-211-73574-9_14","volume":"Suppl 72","author":"T Nagatsu","year":"2007","unstructured":"Nagatsu T, Sawada M (2007) Biochemistry of postmortem brains in Parkinson\u2019s disease: historical overview and future prospects. J Neural Transm Suppl 72:113\u2013120","journal-title":"J Neural Transm"},{"issue":"1","key":"1596_CR149","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1353-8020(09)70004-5","volume":"15","author":"T Nagatsu","year":"2009","unstructured":"Nagatsu T, Sawasa M (2009) l-dopa therapy for Parkinson\u2019s disease: past, present, and future. Parkinsonism Relat Disord 15(1):S3\u2013S8","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"1596_CR150","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/clinchem\/18.9.980","volume":"18","author":"T Nagatsu","year":"1972","unstructured":"Nagatsu T, Udenfriend S (1972) Photometric assay of human dopamine \u03b2-hydroxylase activity in human blood. Clin Chem 18(9):980\u2013983","journal-title":"Clin Chem"},{"issue":"1","key":"1596_CR151","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0003-2697(64)90092-2","volume":"9","author":"T Nagatsu","year":"1964","unstructured":"Nagatsu T, Levitt M, Udenfriend S (1964a) A rapid and simple radioassay for tyrosine hydroxylase activity. Anal Biochem 9(1):122\u2013126","journal-title":"Anal Biochem"},{"issue":"9","key":"1596_CR152","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/S0021-9258(18)93832-9","volume":"239","author":"T Nagatsu","year":"1964","unstructured":"Nagatsu T, Levitt M, Udenfriend S (1964b) Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem 239(9):2910\u20132917","journal-title":"J Biol Chem"},{"issue":"14","key":"1596_CR153","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/0006-2952(72)90007-X","volume":"21","author":"T Nagatsu","year":"1972","unstructured":"Nagatsu T, Mizutani K, Nagatsu I, Matsuura S, Sugimoto T (1972) Pteridine as cofactor or inhibitor of tyrosine hydroxylase. Biochem Pharmacol 21(14):1945\u20131953","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1596_CR154","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0009-8981(77)90193-0","volume":"75","author":"T Nagatsu","year":"1977","unstructured":"Nagatsu T, Kato T, Numata Y, Ikuta K, Sano M, Nagatsu I, Kondo Y, Inagaki S, Iizuka R, Hori A, Narabayashi H (1977) Phenylethanolamine N-methyltransferase activity and other enzymes of catecholamine metabolism inhuman brain. Clin Chim Acta 75(2):221\u2013232","journal-title":"Clin Chim Acta"},{"issue":"2","key":"1596_CR155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00490094","volume":"64","author":"I Nagatsu","year":"1979","unstructured":"Nagatsu I, Karasawa N, Kondo Y, Inagaki S (1979a) Immunocytochemical localization of tyrosine hydroxylase, dopamine-\u03b2-hydroxylase and phenylethanolamine-N-methyltransferase in the adrenal glands of the frog and rat by a peroxidase-antiperoxidase method. Histochemistry 64(2):131\u2013144","journal-title":"Histochemistry"},{"issue":"3","key":"1596_CR156","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-4347(00)81411-5","volume":"163","author":"T Nagatsu","year":"1979","unstructured":"Nagatsu T, Oka K, Kato T (1979b) Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J Chromatogr B 163(3):247\u2013252","journal-title":"J Chromatogr B"},{"issue":"7\u20138","key":"1596_CR157","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s007020050183","volume":"106","author":"I Nagatsu","year":"1999","unstructured":"Nagatsu I, Ikemoto K, Kitahama K, Nishimura A, Ichinose H, Nagatsu T (1999) Specific localization of the guanosine triphosphate (GTP) cyclohydrolase I-immunoreactivity in the human brain. J Neural Transm 106(7\u20138):607\u2013617","journal-title":"J Neural Transm"},{"key":"1596_CR158","first-page":"143","volume":"Suppl 58","author":"T Nagatsu","year":"2000","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari A (2000) Changes in cytokines in Parkinson\u2019s disease. J Neural Transm Suppl 58:143\u2013151","journal-title":"J Neural Transm"},{"key":"1596_CR159","first-page":"1","volume-title":"From east to west: pioneers in Parkinson\u2019s disease in Japan. A historical overview of major achievements in research","year":"2014","unstructured":"Nagatsu T, Takahashi A, Yanagisawa N, Mizuno Y, Kondo T, Takahashi R, Mezaki T, Riederer C, Riederer P (eds) (2014) From east to west: pioneers in Parkinson\u2019s disease in Japan. A historical overview of major achievements in research. QOL Laboratory, Tokyo, pp 1\u201399"},{"issue":"11","key":"1596_CR160","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00702-009-0227-8","volume":"116","author":"A Nakashima","year":"2009","unstructured":"Nakashima A, Hayashi N, Kaneko YS, Mori K, Sabban EL, Nagatsu T, Ota A (2009) Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines. J Neural Transm 116(11):1355\u20131362","journal-title":"J Neural Transm"},{"key":"1596_CR161","first-page":"3","volume-title":"Advanced pharmacology","author":"A Nakashima","year":"2013","unstructured":"Nakashima A, Kaneko YS, Kodani Y, Mori K, Nagasaki H, Nagatsu T, Ota A (2013) Intracellular stability of tyrosine hydroxylase: phosphorylation and protease digestion of the enzyme. In: Eiden L (ed) Advanced pharmacology, vol 68. Academic Press, Burlington, pp 3\u201313"},{"issue":"5","key":"1596_CR163","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0892-0362(02)00211-8","volume":"24","author":"M Naoi","year":"2002","unstructured":"Naoi M, Maruyama Y, Akao Y, Yi H (2002) Dopamine-derived N-mehyl-(R)-salsolinol. Its role in Parkinson\u2019s disease. Neurotoxicol Teratol 24(5):579\u2013591","journal-title":"Neurotoxicol Teratol"},{"key":"1596_CR164","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00702-014-1362-4","volume":"123","author":"M Naoi","year":"2016","unstructured":"Naoi M, Riederer P, Maruyama W (2016) Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression. J Neural Transm 123:91\u2013106","journal-title":"J Neural Transm"},{"key":"1596_CR165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2183\/pjab.57.351","volume":"57","author":"H Narabayashi","year":"1981","unstructured":"Narabayashi H, Kondo T, Hayashi A, Suzuki T, Nagatsu T (1981) l-threo-3,4-dihydroxyphenylserine treatment for akinesia and freezing of parkinsonism. Proc Jpn Acad Ser B 57:351\u2013354","journal-title":"Proc Jpn Acad Ser B"},{"issue":"3","key":"1596_CR166","first-page":"423","volume":"15","author":"H Narabayashi","year":"1987","unstructured":"Narabayashi H, Nakanishi T, Yoshida M, Yanagisawa N, Mizuno Y, Kanazawa K, Kondo T (1987) The therapeutic effects of l-threo-DOPS in Parkinson\u2019s disease. Clin Eval 15(3):423\u2013457","journal-title":"Clin Eval"},{"issue":"4","key":"1596_CR167","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/(SICI)1097-4547(19981115)54:4<450::AID-JNR3>3.0.CO;2-B","volume":"54","author":"K Nishii","year":"1998","unstructured":"Nishii K, Matsushita N, Sawada H, Sano H, Noda Y, Mamiya T, Nabeshima T, Nagatsu I, Hata T, Kiuchi K, Yoshizato H, Nakashima K, Nagatsu T, Kobayashi K (1998) Motor and learning dysfunctions during postnatal development in mice defective in dopamine neuronal transmission. J Neurosci Res 54(4):450\u2013464","journal-title":"J Neurosci Res"},{"issue":"22","key":"1596_CR168","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1021\/bi00396a007","volume":"26","author":"KL O\u2019Malley","year":"1987","unstructured":"O\u2019Malley KL, Anhalt MJ, Martin BM, Kalsoe JR, Winfield SL, Ginns EI (1987) Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5\u2032-alternative splice sites responsible for multiple mRNAs. Biochemistry 26(22):6910\u20136914","journal-title":"Biochemistry"},{"issue":"1","key":"1596_CR169","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/neur.1995.0009","volume":"4","author":"T Ohye","year":"1995","unstructured":"Ohye T, Ichinose H, Ogawa M, Yoshida M, Nagatsu T (1995) Alterations in multiple tyrosine hydroxylase mRNA in the substantia nigra, locus coeruleus and adrenal gland of MPTP-treated parkinsonian monkeys. Neurodegeneration 4(1):81\u201385","journal-title":"Neurodegeneration"},{"issue":"3","key":"1596_CR170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(01)02210-8","volume":"312","author":"T Ohye","year":"2001","unstructured":"Ohye T, Ichinose H, Yoshizawa T, Kanzawa I, Nagatsu T (2001) A new splicing variant for human tyrosine hydroxylase in the adrenal medulla. Neurosci Lett 312(3):157\u2013160","journal-title":"Neurosci Lett"},{"key":"1596_CR171","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1756-6606-7-22","volume":"7","author":"H Okano","year":"2014","unstructured":"Okano H, Yamanaka S (2014) iPS cell technologies: significance and applications to CNS regeneration and disease. Mol Brain 7:22","journal-title":"Mol Brain"},{"issue":"2","key":"1596_CR172","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0304-3940(88)90356-4","volume":"85","author":"N Ozaki","year":"1988","unstructured":"Ozaki N, Nakahara D, Mogi M, Harada M, Kiuchi K, Kaneda N, Miura Y, Kasahara Y, Nagatsu T (1988) Inactivation of tyrosine hydroxylase in rat striatum by 1-methy-4-phenylpyridinium ion. Neurosci Lett 85(2):228\u2013232","journal-title":"Neurosci Lett"},{"issue":"9923","key":"1596_CR173","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(13)61939-X","volume":"383","author":"S Palfi","year":"2014","unstructured":"Palfi S, Grruchaga JM, Ralph GS, Lepetit H, Lavisse S, Buttery PC, Watts C, Miskin J, Kelleher M, Deeley S, Iwamuro H, Lefaucheur JP, Thiriez C, Fenelon G, Lucas C, Brugi\u00e8res P, Grabriel I, Abhay K, Drout X, Tani N, Kas A, Ghaleh B, Le Corvoisier P, Dolphin P, Breen DP, Mason S, Guzman NV, Mazarakis ND, Radcliffe PA, Harrop R, Kingsman SM, Rascol O, Naylor S, Barker RA, Hantraye P, Remy P, Cessaro P, Mitrophanous KA (2014) Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson\u2019s disease: a dose escalation, open-label, phase 1\/2 trial. Lancet 383(9923):1138\u20131146","journal-title":"Lancet"},{"issue":"9949","key":"1596_CR174","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(14)60683-8","volume":"384","author":"PD MED Collaborative Group","year":"2014","unstructured":"PD MED Collaborative Group (2014) Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson\u2019s disease (PD MED): a large, open-label, programmatic randomized trial. Lancet 384(9949):1196\u20131205","journal-title":"Lancet"},{"issue":"24","key":"1596_CR175","doi-asserted-by":"crossref","first-page":"8210","DOI":"10.1523\/JNEUROSCI.5456-13.2014","volume":"34","author":"C Pifl","year":"2014","unstructured":"Pifl C, Rajput A, Reither H, Blesa J, Cavada C, Obeso JA, Rajput A, Hornykiewicz O (2014) Is Parkinson\u2019s disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum. J Neurosci 34(24):8210\u20138218","journal-title":"J Neurosci"},{"issue":"8","key":"1596_CR176","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s disease and Alzheimer\u2019s disease brain. Neurology 38(8):1285\u20131291","journal-title":"Neurology"},{"issue":"5321","key":"1596_CR177","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Deheijia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenrous ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos Johnson WG, Lazzarini AM, Duvoiosin RC, DiIrio G, Golbe LI, Nussbaum RL (1997) Muation in the alpha-synuclein gene identified in familial Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"4","key":"1596_CR178","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF00499439","volume":"281","author":"M Puig","year":"1974","unstructured":"Puig M, Bartholini G, Pletscher P (1974) Formation of noradrenaline in the rat brain in from the four isomers of 3,4-dihydroxyphenylsrine. Naunyn-Schmiedberg\u2019s Arch Pharm 281(4):443\u2013446","journal-title":"Naunyn-Schmiedberg\u2019s Arch Pharm"},{"issue":"1","key":"1596_CR179","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1471-4159.1988.tb13250.x","volume":"50","author":"WD Rausch","year":"1988","unstructured":"Rausch WD, Hirata Y, Nagatsu T, Riederer P, Jellinger K (1988) Tyrosine hydroxylase activity in caudate ncleus from Parkinson\u2019s disease: effects of iron and phosphorylating agents. J Neurochem 50(1):202\u2013208","journal-title":"J Neurochem"},{"key":"1596_CR180","unstructured":"Reichmann H, Riederer P (1989) Biochemishe Analyse der Atmungskettenkomplex verschiedener Hirnregionen von Patienten mit M. Parkinson. Symposium zu Morbus Parkinson und andere Basalganglienkrankungen, Ministerium f\u00fcr Forschung und Technologie (BMBF), Bad Kissingen (Germany): 1.2.6. p44"},{"issue":"Suppl 2","key":"1596_CR181","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.parkreldis.2008.04.009","volume":"14","author":"P Riederer","year":"2008","unstructured":"Riederer P, Youdim MB, Mandel S, Gerlach M, Gr\u00fcnblatt E (2008) Genomic aspects of sporadic Parkinson\u2019s disease. Parkinsonism Relat Disord 14(Suppl 2):S88\u2013S91","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"1596_CR182","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1073\/pnas.71.3.872","volume":"71","author":"RA Rush","year":"1974","unstructured":"Rush RA, Thomas PE, Nagatsu T, Udenfriend D (1974) Comparison of human serum dopamine \u03b2-hydroxylase levels by radioimmunoassay and enzyme activity. Proc Natl Acad Sci USA 71(3):872\u2013874","journal-title":"Proc Natl Acad Sci USA"},{"key":"1596_CR183","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1196\/annals.1314.010","volume":"1032","author":"EL Sabban","year":"2004","unstructured":"Sabban EL, Hebert MA, Liu X, Nankova B, Serova L (2004a) Differential effects of stress on gene transcription factors in catecholamine systems. Ann N Y Acad Sci 1032:130\u2013140","journal-title":"Ann N Y Acad Sci"},{"key":"1596_CR184","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1196\/annals.1296.046","volume":"1018","author":"EL Sabban","year":"2004","unstructured":"Sabban EL, Nankova BB, Serova LI, Kvetnansky R, Liu X (2004b) Molecular regulation of gene expression of cathcholamine biosynthetic enzymes by stress: sympathetic ganglia versus adrenal medulla. Ann N Y Acad Sci 1018:370\u2013377","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"1596_CR185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jnc.12796","volume":"131","author":"MF Salvatore","year":"2014","unstructured":"Salvatore MF, Disbrow EA, Emborg ME (2014) Peripheral and cognitive signs: delineating the significance of impaired catecholamine metabolism in Parkinson\u2019s disease progression. J Neurochem 131(2):129\u2013133","journal-title":"J Neurochem"},{"key":"1596_CR186","doi-asserted-by":"crossref","unstructured":"Sano A (2000) Biochemistry of the extrapyramidal system. Parkinsonism Relat Disord 6:3-6 (original: Sano I (1960) Shinkei Kenkyu No Shinpo (Japanese), Advances in Neurological Sciences, vol 5, pp 42\u201348. ISSN:0001-8724","DOI":"10.1016\/S1353-8020(99)00046-2"},{"key":"1596_CR187","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0006-3002(59)90652-3","volume":"32","author":"I Sano","year":"1959","unstructured":"Sano I, Gamo T, Kakimoto Y, Taniguchi K, Takesada M, Nishinuma K (1959) Distribution of catechol compounds in human brain. Biochim Biopys Acta 32:586\u2013587","journal-title":"Biochim Biopys Acta"},{"key":"1596_CR188","first-page":"3","volume":"1","author":"M Sawada","year":"2007","unstructured":"Sawada M, Imamura K, Hashizume Y, Nagatsu T (2007) Role of cytokines in inflammatory process in Parkinson\u2019s disease: interaction between dopaminergic neurons and microglia. CNS Drugs 1:3\u201310","journal-title":"CNS Drugs"},{"issue":"8649","key":"1596_CR189","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","volume":"333","author":"AHV Schapira","year":"1989","unstructured":"Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson\u2019s disease. Lancet 333(8649):1269","journal-title":"Lancet"},{"key":"1596_CR190","first-page":"251","volume":"56","author":"RS Schwab","year":"1951","unstructured":"Schwab RS, Amador LV, Lettvin JY (1951) Apomorphine in Parkinson\u2019s disease. Trans Am Neurol Assoc 56:251\u2013253","journal-title":"Trans Am Neurol Assoc"},{"issue":"5","key":"1596_CR191","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.stemcr.2015.02.019","volume":"4","author":"A Shaltouki","year":"2015","unstructured":"Shaltouki A, Sivapatham R, Pei Y, Gerencser AA, Mom\u010dilovi\u0107 O, Rao MS, Zeng X (2015) Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines. Stem Cell Rep 4(5):847\u2013859","journal-title":"Stem Cell Rep"},{"key":"1596_CR192","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1089\/10430340050083243","volume":"11","author":"Y Shen","year":"2000","unstructured":"Shen Y, Muramatsu S, Ikeguchi K, Fujimoto K, Fan DS, Ogawa K, Urabe M, Kume A, Nagatsu I, Urano F, Suzuki T, Ichinose H, Nagatsu T, Monahan J, Nakano I, Ozawa K (2000) Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, and GTP cyclohydrolase I for gene therapy. Hum Gene Ther 11:1509\u20131519","journal-title":"Hum Gene Ther"},{"issue":"3","key":"1596_CR193","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/77060","volume":"25","author":"H Shimura","year":"2000","unstructured":"Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nature Genet 25(3):302\u2013305","journal-title":"Nature Genet"},{"issue":"6","key":"1596_CR194","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2010.07132.x","volume":"118","author":"J Sian-H\u00fclsmann","year":"2011","unstructured":"Sian-H\u00fclsmann J, Mandel S, Youdim MB, Riederer P (2011) The relevance of iron in the pathogenesis of Parkinson\u2019s disease. J Neurochem 118(6):939\u2013957","journal-title":"J Neurochem"},{"issue":"6","key":"1596_CR195","first-page":"549","volume":"3","author":"S Spector","year":"1967","unstructured":"Spector S, Gordon R, Sjoerdsma A, Udenfriend S (1967) End product inhibition of tyrosine hydroxylase as a possible mechanism of regulation of norepinephrine synthesis. Pharmacol Rev 3(6):549\u2013555","journal-title":"Pharmacol Rev"},{"issue":"8","key":"1596_CR196","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1021\/bi00123a004","volume":"31","author":"C Sumi-Ichinose","year":"1992","unstructured":"Sumi-Ichinose C, Ichinose H, Takahashi E, Hori T, Nagatsu T (1992) Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic l-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. Biochemistry 31(8):2229\u20132238","journal-title":"Biochemistry"},{"issue":"2","key":"1596_CR197","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1471-4159.1995.64020514.x","volume":"64","author":"C Sumi-Ichinose","year":"1995","unstructured":"Sumi-Ichinose C, Hasegawa S, Ichinose H, Sawada H, Kobayashi K, Sakai M, Fujii T, Nomura T, Nagatsu I, Hagino Y, Fujita K, Nagatsu T (1995) Analysis of alternative promoters that regulate tissue-specific expression of human aromatic l-amino acid decarboxylase. J Neurochem 64(2):514\u2013524","journal-title":"J Neurochem"},{"issue":"44","key":"1596_CR198","doi-asserted-by":"crossref","first-page":"10062","DOI":"10.1074\/jbc.M102237200","volume":"276","author":"C Sumi-Ichinose","year":"2001","unstructured":"Sumi-Ichinose C, Urano F, Kuroda R, Ohye T, Kojima M, Tazawa M, Shiraishi H, Hagino Y, Nagatsu T, Nomura T, Ichinose H (2001) Catecholamine and serotonin are differentially regulated by tetrahydrobiopterin. A study from 6-pyruvoyltetrahydropterin knockout mice. J Biol Chem 276(44):10062\u201310071","journal-title":"J Biol Chem"},{"issue":"1","key":"1596_CR199","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1172\/JCI21137","volume":"115","author":"Y Takagi","year":"2005","unstructured":"Takagi Y, Takahashi J, Saiki H, Morizane A, Hayashi T, Kishi Y, Fukuda H, Okamoto Y, Koyanagi M, Ideguchi M, Hayashi H, Imazato T, Kawasaki H, Suemori H, Omachi S, Iida H, Itoh N, Nakatsuji N, Sasai Y, Hashimoto N (2005) Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 115(1):102\u2013109","journal-title":"J Clin Invest"},{"issue":"4","key":"1596_CR200","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"136","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 136(4):663\u2013676","journal-title":"Cell"},{"issue":"5","key":"1596_CR201","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"13","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 13(5):861\u2013872","journal-title":"Cell"},{"issue":"3","key":"1596_CR202","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37(3):510\u2013518","journal-title":"Neurobiol Dis"},{"issue":"12","key":"1596_CR203","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00702-014-1238-7","volume":"121","author":"I Tekin","year":"2014","unstructured":"Tekin I, Roskoski R Jr, Carkaci-Salli N, Vrana KE (2014) Complex molecular regulation of tyrosine hydroxylase. J Neural Transm 121(12):1451\u20131481","journal-title":"J Neural Transm"},{"issue":"1","key":"1596_CR204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3470001","volume":"347","author":"B Th\u00f6ny","year":"2000","unstructured":"Th\u00f6ny B, Auerbach G, Blau N (2000) Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347(1):1\u201316","journal-title":"Biochem J"},{"issue":"1","key":"1596_CR205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0031-6997(25)07173-X","volume":"18","author":"S Udenfriend","year":"1966","unstructured":"Udenfriend S (1966) Tyrosine hydroxylase. Pharmacol Rev 18(1):43\u201351","journal-title":"Pharmacol Rev"},{"issue":"5","key":"1596_CR206","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0006-2952(65)90103-6","volume":"14","author":"S Udenfriend","year":"1965","unstructured":"Udenfriend S, Zalzman-Nirenberg P, Nagatsu T (1965) Inhibitors of purified beef adrenal tyrosine hydroxylase. Biochem Pharmacol 14(5):837\u2013845","journal-title":"Biochem Pharmacol"},{"issue":"5674","key":"1596_CR207","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DJ, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304(5674):1158\u20131160","journal-title":"Science"},{"issue":"6","key":"1596_CR208","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s004390050756","volume":"102","author":"LP Heuvel van den","year":"1998","unstructured":"van den Heuvel LP, Luiten B, Smeitink JA, de Rijk-van Andel JF, Hyland K, Steenbergen-Spanjers GC, Janssen RJ, Wevers RA (1998) A common point mutation in the tyrosine hydroxylase gene in autosomal recessive l-DOPA-responsive dystonia in the Dutch population. Hum Genet 102(6):644\u2013646","journal-title":"Hum Genet"},{"issue":"2\u20133","key":"1596_CR209","first-page":"168","volume":"11","author":"US Euler von","year":"1946","unstructured":"von Euler US (1946) The presence of a substance with sympathin E properties in spleen extracts. Acta Physiol Scand 11(2\u20133):168\u2013186","journal-title":"Acta Physiol Scand"},{"issue":"6","key":"1596_CR210","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1046\/j.1471-4159.1994.63062014.x","volume":"63","author":"KE Vrana","year":"1994","unstructured":"Vrana KE, Walker SJ, Rucker P, Liu X (1994) A carboxyl terminal leucine zipper is required for tyrosine hydroxylase formation. J Neurochem 63(6):2014\u20132020","journal-title":"J Neurochem"},{"issue":"1","key":"1596_CR211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(00)81779-1","volume":"95","author":"D Watanabe","year":"1998","unstructured":"Watanabe D, Inokawa H, Hashimoto K, Suzuki N, Kano M, Shigemoto R, Hirano T, Toyama K, Kaneko S, Yokoi M, Moriyoshi K, Suzuki M, Kobayashi K, Nagatsu T, Kreitman RJ, Pastan I, Nakanishi S (1998) Ablation of cerebellar Golgi cells disrupts synaptic integration involving GABA inhibition and NMDA receptor activation in motor coordination. Cell 95(1):17\u201327","journal-title":"Cell"},{"issue":"Suppl 1","key":"1596_CR212","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1002\/mds.870080504","volume":"8","author":"BH Youdim","year":"1993","unstructured":"Youdim BH, Riederer P (1993) The relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in Parkinson\u2019s disease. Mov Disord 8(Suppl 1):S8\u2013S13","journal-title":"Mov Disord"},{"issue":"4","key":"1596_CR213","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","volume":"7","author":"BH Youdim","year":"2006","unstructured":"Youdim BH, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7(4):295\u2013309","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"1596_CR214","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/318198","volume":"68","author":"CP Zabetian","year":"2001","unstructured":"Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, Kim KS, Kim CH, Malison RT, Gelerntner J, Cubells JF (2001) A quantitative-trait analysis of human plasma dopamine \u03b2-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68(2):515\u2013522","journal-title":"Am J Hum Genet"},{"issue":"7","key":"1596_CR215","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0092-8674(95)90145-0","volume":"83","author":"QY Zhou","year":"1995","unstructured":"Zhou QY, Palmiter RD (1995) Dopamine deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83(7):1197\u20131209","journal-title":"Cell"},{"key":"1596_CR216","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/374640a0","volume":"374","author":"Q-Y Zhou","year":"1995","unstructured":"Zhou Q-Y, Quaife CJ, Palmiter RD (1995) Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse development. Nature 374:640\u2013643","journal-title":"Nature"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-016-1596-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-016-1596-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-016-1596-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:49:46Z","timestamp":1749041386000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-016-1596-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":219,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1596"],"URL":"https:\/\/doi.org\/10.1007\/s00702-016-1596-4","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}